510(k) for ESTECH's perfusion cannula:
This article was originally published in Clinica
ESTECH has received marketing clearance from the US FDA for its remote access perfusion cannula. The device is designed to stop the heart and provide arterial blood flow, allowing cardiac surgery to be performed in a less invasive way through small incisions between the ribs. The multi-function ESTECH cannula delivers blood flow directly to the central aorta in its natural direction unlike other devices which provide blood flow in the opposite direction. Reverse blood flow has been implicated in the occurrences of aortic tears, said the Danville, California-based company.
You may also be interested in...
COVID-19 Vaccines: ACIP’s Allocation Proposal Prioritizes Long-Term Care Residents, Essential Workers
First group to receive vaccine would comprise health care personnel and residents of long-term care facilities; next in line are non-health care essential workers, who would take priority over adults with high-risk medical conditions and those ages 65 years and older, according to the CDC advisory committee’s proposed allocation framework.
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.